|
CA2779736A1
|
|
Stable pharmaceutical formulations comprising lubiprostone
|
|
CA2773588A1
|
|
Choline fenofibrate delayed release compositions
|
|
WO2011026234A1
|
|
Clarithromycin extended-release tablet
|
|
CA2651696A1
|
|
Modified release tablets comprising tramadol
|
|
CA2586236A1
|
|
Compositions comprising co-precipitate of eplerenone and a water-soluble excipient
|
|
CA2578325A1
|
|
Megestrol acetate suspension
|
|
CA2572004A1
|
|
Tablets comprising entacapone and crospovidone
|
|
CA2521272A1
|
|
Capsules comprising topiramate
|
|
CA2476101A1
|
|
Extended-release capsules comprising venlafaxine hydrochloride
|
|
CA2469327A1
|
|
Propafenone hydrochloride capsules containing microtablets
|
|
CA2469339A1
|
|
Sustained release propafenone hydrochloride capsules
|
|
NZ530915A
|
|
Antimicrobial oral rinse solid composition to be dispersed in water prior to use in the oral cavity
|
|
CA2440172A1
|
|
Itraconazole solution
|
|
CA2489572A1
|
|
Extended-release tablets comprising divalproex sodium
|
|
AU2003238590A1
|
|
Tablets comprising ciprofloxacin hydrochloride
|
|
AU2003204233A1
|
|
Magnesium salt of S-omeprazole
|
|
CA2484758A1
|
|
Extended release tablets comprising felodipine
|
|
AU2003215461A1
|
|
Stable tablets comprising pergolide mesylate
|
|
CA2420180A1
|
|
Tablets comprising modafinil
|
|
WO03063867A1
|
|
Stable saccharide-free tablets comprising a salt of quinapril or moexipril
|
